News
Described new predictors of mortality in severe pulmonary embolism
A study carried out by researchers from IDIBELL and the Bellvitge University Hospital has described new predictors of mortality in the endovascular treatment of severe pulmonary embolism.
Breast cancer cells create collagen shields to protect themselves from the immune system
A study published in Nature with the participation of IDIBELL and ICO shows that a protein on the surface of mammary tumor cells binds to extracellular collagen and aligns it to block the entry of immune cells.
Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery
Dr. Joan Fabregat Prous, a principal investigator of the IDIBELL hepato-biliary-pancreatic pathology research group and head of the section of the General and Digestive Surgery Service of the Bellvitge University Hospital, received the “Pere Virgili Award” on October 14th. The event took place at the Royal Academy of Medicine of Catalonia.
A team of neuroscientist from IDIBELL performed an experiment about musical curiosity at Sónar+D
Music plays a key role in our lives: it has the inherent ability to evoke a wide range of emotions and feelings and it is used as a powerful mood regulator. But strong individual differences have been observed in the intrinsic motivation to look for new music and enjoy it. For example, while some people […]
Adolescents consumed less alcohol, cannabis, and tobacco during lockdown
This is one of the conclusions of a study carried out within the framework of the DESKcohort project, in which 303 people between 14 and 18 years old participated
A study identifies risk factors for severe COVID-19 in HIV patients
Results show that people with HIV who suffer from other chronic diseases, have a detectable viral load in their blood, were born outside Spain and/or are over 65 years old, could have a higher risk of suffering from severe COVID-19.
A study estimates the number of people at high risk of developing lung cancer in Spain
The results of this study have been published in the scientific journal Archives of Bronconeumology and it has been lead by members of the Early Cancer Detection group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan nstitute of Oncology (ICO).
The PhD Day returns this year stronger than ever
Last Friday, October 22, the sixth edition of IDIBELL’s PhD Day took place in the Faculty of Medicine and Health Sciences of the University of Barcelona. In this edition, it has been presented 10 oral communications and 44 scientific posters.